Sort
21,281 grants matching “influenza”
TFH-TARGETING GENETIC ADJUVANTS TO PROMOTE DURABLE ANTI-INFLUENZA STEM ANTIBODIES IN OLDER ADULTS.
$599,980Kentner Singleton · Tendel Therapies Inc. · N43 · FY2023 · AI
SBIR TOPIC 081: ADJUVANT DEVELOPMENT FOR VACCINES AGAINST INFECTIOUS OR IMMUNE-MEDIATED DISEASES
$599,977Paul Guyre · Celdara Medical, Llc · N43 · FY2020 · AI
Strengthening Influenza Surveillance Networks in Morocco
$599,972Rajae Berrada El Aouad · Ministry Of Health, Morroco · U51 · FY2010 · CI
DEVELOPMENT OF VESIVAX CO-ADJUVANT FORMULATION OF 2E151 for flu vaccines
$599,925Sam Onho · Molecular Express, Inc. · N43 · FY2023 · AI
MULTIVALENT QS-18 PROTEIN NANOPARTICLES FOR A BROADLY PROTECTIVE INFLUENZA VIRUS VACCINE
$599,806Kentner Singleton · Pop Biotechnologies, Inc · N43 · FY2023 · AI
Adjuvant Development for a Thermostable Respiratory Influenza Vaccine
$599,749Universal Stabilization Technologies · N01 · FY2018 · AI
Multiuser facility for flow cytometry and sorting
$599,734Walter J Esselman · Michigan State University · S10 · FY2011 · RR
Oregon Child Absenteeism due to Respiratory Disease Study 2 Using Influenza-like Illness-specific School Absenteeism as an Early Warning System for Detecting Community Influenza
$599,703Jonathan L Temte · University Of Wisconsin-Madison · U01 · FY2019 · CK
Tfh dysfunction in HIV and Aging
$599,681Savita Pahwa · University Of Miami School Of Medicine · R01 · FY2024 · AG
Oregon Child Absenteeism due to Respiratory Disease Study 2 Using Influenza-like Illness-specific School Absenteeism as an Early Warning System for Detecting Community Influenza
$599,676Jonathan L Temte · University Of Wisconsin-Madison · U01 · FY2020 · CK
Oregon Child Absenteeism due to Respiratory Disease Study 2 Using Influenza-like Illness-specific School Absenteeism as an Early Warning System for Detecting Community Influenza
$599,648Jonathan L Temte · University Of Wisconsin-Madison · U01 · FY2018 · CK
RATIONAL DEVELOPMENT OF A COMBINATION NANOPARTICLE ADJUVANT FOR INFLUENZA.
$599,629Mark Orr · Hdt Bio Corporation · N43 · FY2019 · AI
CFI Pathogen Inactivation of Human Plasma Units
$599,617Trevor P. Castor · Aphios Corporation · R44 · FY2018 · HL
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
$599,601Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2024 · CA
DEVELOPMENT OF TOLL-LIKE RECEPTOR AGONISTS TO STRENGTHEN SUBLINGUAL VACCINES.
$599,582Neil Fanger · Virtici, Llc · N43 · FY2022 · AI
Nanoemulsions as novel adjuvents for influenza virus vaccines
$599,570Yoshihiro Kawaoka · University Of Wisconsin-Madison · U01 · FY2009 · AI
A more durable and universal adjuvanted influenza vaccine through synthetic biology
$599,526Chase Kempinski · Enepret, Inc. · N43 · FY2025 · AI
Oregon Child Absenteeism due to Respiratory Disease Study 2 Using Influenza-like Illness-specific School Absenteeism as an Early Warning System for Detecting Community Influenza
$599,508Jonathan L Temte · University Of Wisconsin-Madison · U01 · FY2017 · CK
Combination Adjuvants to Program Durable Immunity to Respiratory Viral and Fungal Pathogens
$599,483Marulasiddappa Suresh · University Of Wisconsin-Madison · U01 · FY2021 · AI
Mindfulness based stress reduction for family caregivers of dementia patients
$599,479Jan A Moynihan · University Of Rochester · R01 · FY2017 · AG
Nanoemulsions as novel adjuvents for influenza virus vaccines
$599,438Yoshihiro Kawaoka · University Of Wisconsin-Madison · U01 · FY2007 · AI
Engineering pluripotent stem cells to evade and promote immunity
$599,236Christopher Michael Sturgeon · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · EB
Risk of Influenza Infection In A Vaccinated Obese Population
$599,156Melinda A. Beck · Univ Of North Carolina Chapel Hill · R01 · FY2009 · AI
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo
$599,112Sumit K Chanda · Icahn School Of Medicine At Mount Sinai · U19 · FY2018 · AI
Respiratory Viruses and Airflow Obstruction after HCT
$599,041Michael J Boeckh · Fred Hutchinson Cancer Research Center · R01 · FY2008 · HL